Testing oropharyngeal secretions for SARS-CoV-2 resulted in fewer false-negative results among patients who seemed to have recovered from the infection, compared with nasal-sample testing, according to a study published in the Journal of Dental Research. Although using oropharyngeal secretions improved nucleic acid amplification testing for the novel coronavirus, it should only be considered a surrogate for...